Carlsbad, Calif.-based Aurora Spine Corp. has announced financial results for the third quarter of 2024, ending Sept. 30, recording $4,767,121 in revenue.
Here are five things to know about the company's third-quarter financials, according to an Oct. 24 news release:
1. Quarterly revenue grew 21% up from $3,949,530 in the same quarter last year.
2. Aurora saw net income of $71,120, for third-quarter 2024 compared to a loss of ($249,618) in the third quarter last year.
3. The nine-month period ending Sept. 30 saw a net loss of ($349,911) compared to a net loss of ($1,394,968) in the comparable period last year, a net improvement of $1,045,057.
4. Third-quarter sales of $4,767,121 increased by $687,578 or 16.8%,compared to Q2 2024's $4,079,543 and was up 10.7% compared to the same periods in 2023.
5. Sales of Aurora's SiLO-TFX SI joint implant and SiLO allograft implant made up 48.2%, or $2.3 million in sales, in the third quarter compared to 30.5% or $1.2 million in the same period the previous year. Sales increased 62.7% from Q1 2024 to Q3 2024.